Ways2Capital Reviews : AstraZeneca Receives Marketing Permission For Durvalumab (ImfinziTM) In India

AstraZeneca Pharma India Limited (AZPIL) announced that it has received Import & Market permission for Durvalumab (ImfinziTM) in Ind...
Read More

Ways2Capital Reviews : Uncertainty In OPEC Meeting Outcome Leads To Crude Oil Volatility

OPEC meeting along with some non-OPEC members including Russia is underway in Vienna. All eyes are on the outcome and the key things to ...
Read More

Ways2Capital Reviews : Tata Motors To Complete Half Century Of CV Launches This Fiscal

India’s largest commercial vehicle manufacturer, Tata Motors Limited (TML) has put in place aggressive plans to further strengthen its p...
Read More

Ways2Capital Reviews : DIL Ltd. Approves Scheme Of Amalgamation With Subsidiary, Fermenta Biotech Ltd.

DIL Ltd. announced that the Board of Directors at its meeting held on June 21, 2018 has approved the Scheme of Amalgamation (‘Scheme’) w...
Read More

Ways2Capital Reviews : Daimler Profit Warning Sends Shivers Across Automakers On A Warm Summer Day

Germany-based luxury carmaker Daimler, which owns the marquee Mercedes-Benz car brand cut its CY2018 profit forecast amid the ongoing t...
Read More

Ways2Capital Reviews : JSW Steel To Invest $500mn To Upgrade Acero Junction Plant In USA

JSW Steel has proposed to invest up to $500mn in its newly acquired unit, Acero Junction Inc, located in Ohio, USA. Acero Junction is an...
Read More

Ways2Capital Reviews : Japanese Stocks Decline On Concern Over Global Trade Outlook

Japanese stocks fell as the yen stayed steady against the dollar amid investor concern that global trade tensions will take a toll on ec...
Read More